Real-world Outcomes of 5-Fu-based Second-Line Therapy in Patients with Advanced Biliary Tract Cancer Refractory to Gemcitabine and Cisplatin-Based Treatment
ANNALS OF ONCOLOGY(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF ONCOLOGY(2024)